-
FDA approves new leukemia drug
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.
The FDA approved South San Francisco, Calif.-based Talon Therapeutics' Marqibo (vincristine sulfate liposome), an injectable drug for Philadelphia chromosome-negative acute lymphoblasic leukemia, or Ph-negative ALL.
-
Reports: Texas program aims to curb drug abuse
NEW YORK — A new program in Texas aims to track prescribed controlled substances to catch dealers and abusers, according to published reports.
The Associated Press reported that the Texas Department of Public Safety had created Prescription Access in Texas, an online database that healthcare professionals and law enforcement officials can immediately access to see what drugs a patient has received in the state in the last year.